JE
RMD icon

JMAC Enterprises’s ResMed RMD Stock Holding History

JMAC Enterprises’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-971
Closed -$202K – 192
2022
Q4 		$202K Hold
971
– – 0.06% 169
2022
Q3 		$212K Sell
971
-335
-26% -$76.2K 0.06% 161
2022
Q2 		$274K Hold
1,306
– – 0.07% 151
2022
Q1 		$317K Hold
1,306
– – 0.07% 146
2021
Q4 		$314K Buy
+1,306
New +$339K 0.07% 144

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JMAC Enterprises's RMD Position: Q1 2023 in Review

JMAC Enterprises sold out of ResMed (RMD) in Q1 2023, closing a stake of 971 shares — an estimated $202K sold.

JMAC Enterprises first reported a position in RMD in Q4 2021 and held it in 5 quarters. The position peaked at $317K in Q1 2022. 676 funds tracked by Wall St. Rank hold RMD as of Q1 2023.

  • JMAC Enterprises reported no remaining ResMed position as of Q1 2023 after selling out during the quarter.
  • JMAC Enterprises sold 971 ResMed shares in Q1 2023, an estimated $202K.
  • JMAC Enterprises first reported a position in ResMed in Q4 2021 and held it in 5 quarters.
  • JMAC Enterprises's ResMed position peaked at $317K in Q1 2022.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q1 2023.

Based on JMAC Enterprises's 13F filing for Q1 2023, filed 20 Apr 2023.